Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 545781 - 545800 out of 553697 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FG02) ramucirumab (adm: P) | CYRAMZA 100 MG/10ML | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms | EliLilly&Company |
| USA | (L01FG02) ramucirumab (adm: P) | CYRAMZA 100 MG/10ML | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms | EliLilly&Company |
| USA | (L01FG02) ramucirumab (adm: P) | CYRAMZA 500MG/50ML | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms | EliLilly&Company |
| USA | (L01FG02) ramucirumab (adm: P) | CYRAMZA 500MG/50ML | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms | EliLilly&Company |
| USA | (L01FX02) gemtuzumab ozogamicin | MYLOTARG 5MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerInc. |
| USA | (L01FX02) gemtuzumab ozogamicin | MYLOTARG 5MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PfizerInc. |
| USA | (L01FX04) ipilimumab (adm: P) | YERVOY 200MG/40ML SDV | 40ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FX04) ipilimumab (adm: P) | YERVOY 200MG/40ML SDV | 40ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FX04) ipilimumab (adm: P) | YERVOY 50MG/10ML SDV | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FX04) ipilimumab (adm: P) | YERVOY 50MG/10ML SDV | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FX05) brentuximab vedotin (adm: P) | ADCETRIS 50MG/10.5ML INJ | 10.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | PfizerInc. |
| USA | (L01FX05) brentuximab vedotin (adm: P) | ADCETRIS 50MG/10.5ML INJ | 10.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | PfizerInc. |
| USA | (L01FX06) dinutuximab beta | UNITUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
| USA | (L01FX06) dinutuximab beta | UNITUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
| USA | (L01FX07) blinatumomab (adm: P) | BLINCYTO 35MCG INJ VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenUSA,Inc. |
| USA | (L01FX07) blinatumomab (adm: P) | BLINCYTO 35MCG INJ VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenUSA,Inc. |
| USA | (L01FX08) elotuzumab (adm: P) | EMPLICITI 300MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbCompany |
| USA | (L01FX08) elotuzumab (adm: P) | EMPLICITI 300MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbCompany |
| USA | (L01FX08) elotuzumab (adm: P) | EMPLICITI 400MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbCompany |
| USA | (L01FX08) elotuzumab (adm: P) | EMPLICITI 400MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbCompany |
Pages
